Clinical Trials Logo

Drug Abuse in Pregnancy clinical trials

View clinical trials related to Drug Abuse in Pregnancy.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03911739 Recruiting - Pregnancy Related Clinical Trials

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study

MOMs-INO
Start date: June 14, 2021
Phase: Phase 3
Study type: Interventional

This is a sub-study of NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs; Unique protocol ID: 2019-0429-1). Caretakers of the infants delivered by MOMs participants will be offered the opportunity to enroll in this sub-study, which is designed to evaluate the impact of extended-release buprenorphine (BUP-XR), relative to sublingual buprenorphine (BUP-SL), on infant neurodevelopment. The additional data collected in this sub-study will be combined with data from the main MOMs trial.